ORBITA-STAR at #EuroPCR is a fascinating & successful study of type of chest pain as a predictor of PCI success. Very difficult to ascertain if angina caused by ischemia is what patients felt. This was a concern of Gruentzig's 40 yrs ago! Christopher Rajkumar Rasha Al-Lamee #AngioHistory

Congratulations to Dr. Catalin Toma, MD, whose paper, 'Acute outcomes for the full US cohort of the FLASH mechanical thrombectomy registry in pulmonary embolism,' was recognized at #EuroPCR for best original research!
#pulmonaryembolism #PE #thrombectomy

#IVUS and #OCT are simply great to guide bIfurcation and LM #PCI . They also increased our knowledge in the field. In the absence of them, operators should be committed to offering a similar PCI efficacy. This last #EBC consensus docunent provides very practical insights!

#EuroPCR #PCRNextGen
All you need to know about bifurcations!

📍Happening now at Room 351
🗣️Dejan Milasinovic Nicola Ryan Asad Shabbir

MIЯVΛƬ #IC Antonin Trimaille Maurizio taramasso Julio Echarte A.Nazmi Calik Carlos Luqueño Lynne Hinterbuchner Belén Cid Alvarez Marta Kaluzna-Oleksy elena Goran Stankovic, MD, PhD

With the winners of #EAPCI fellowship grants at #EuroPCR 2024 👏👏👏👏👏👏👏👏
#riseandlift EAPCIPresident PCRonline 🫀 Salvatore Brugaletta

#EuroPCR PCRonline 🫀 #LBCT

Roller Coaster trial w Shockwave Medical Stable vs ACS w OCT substudy l

🔺30-50% of patients presenting with ACS
🔺Higher risk than stable CAD (thrombotic/bleeding risk, HF).
🔺Similar Procedural success rate, MSA and stent expansion.
🔺Higher MACE during

#NextGen CTO session…
…fuuuullll room!!!

#EducationFirst at #EuroPCR by:
A.Nazmi Calik
Giuseppe Di Gioia
Stelios Pyxaras

🚨Flying 🎤 in the room🚨

Summary of #HFpEF diagnostic scores to facilitate clinical practice

It takes time though...
An easy webtool to help you is available!
🌐 cardiologytools.com/hfpef-calculat…

📄 background: doi.org/10.1002/ehf2.1…

#HeartFailure 2024 Rui Terenas Baptista
Henry Han #HeartFailure #CardioTwitter

Can we say that this is the trial/point of no-return? Anyway… important data to fuel #heatteam discussions since tomorrow morning!!!

Great day today for vulnerable plaque (VP) PCI! Superior to OMT. Guess who was there? Jim Muller father of VP, Patrick Serruys and Gregg Stone. Long history for us guys in VP + PCI.⁦⁦Gregg W. Stone MD⁩ ⁦C. Michael Gibson MD⁩ ⁦Ron Waksman⁩ ⁦B. Hadley Wilson MD⁩

In this meta-analysis of 26 RCTs we found a favorable effect of thrombus aspiration on post-infarction LV remodeling, ultimately influenced by mean ischemic time, target vessel and device employed. Available online on #IJC internationaljournalofcardiology.com/article/S0167-…

Finally after 2000 years, one in a million CTO patient with beautiful septal collaterals for 100% success retrograde:)

sciencedirect.com/science/articl…
Domenico D'Amario Outside of the Box 🇭🇷🇪🇺 Emiliano Bianchini
High-dose statins in preventing mvo: the devil lies in details

Cardiology Glenfield 🫀 this is so inappropriate on so many levels. Being a TAVR operator is not just about deploying a valve, but working up the pt for the optimal mx of their AS, managing the patient prior to procedure and dealing with complications. This is not safe for patients

Our 2nd part (2/2) of the large nationwide analysis on coronary artery aneurysms - In-hospital outcomes and conditions in patients with acute coronary syndrome sciencedirect.com/science/articl…

Our first part (1/2) of the large nationwide analysis of coronary aneurysms entitled In-hospital outcomes and conditions associated with coronary artery aneurysms in chronic coronary syndrome sciencedirect.com/science/articl…

#HeartFailure2023 was a blast!

🙏🏻humbled to chair 4 wonderful sessions
🔥excited to see #HFAYoung growing and highly engaged
⚙️fantastic “how-to” interactive sessions and late-breaking science

⚡️But my personal highlight was the message that the HFA represents all of us, and

Great to catch up with colleagues and friends at HFA Young meeting in beautiful Prague #HFA #HeartFailure2023 #HFA Young